Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials

By Hoff Camilla Molich   Lassen Pernille   Eriksen Jesper Grau   Hansen Hanne Sand   Specht Lena   Overgaard Marie   Grau Cai   Johansen Jørgen   Bentzen Jens   Andersen Lisbeth   Evensen Jan F.   Overgaard Jens  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1006-1014

Informa Healthcare

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment? - results of a phase I/II trial

By Milano G.   McLeod H.L.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study

By Constenla Manuel   Garcia-Arroyo Ramon   Lorenzo Isabel   Carrete Nancy   Campos Begoña   Palacios Patricia  

Gastric Cancer, Vol. 5, Iss. 3, 2002-09 ,pp. : 142-147

Springer Publishing Company

Access to resources Recommend Favorite

Autoregulation of 5-fluorouracil metabolism

By McLeod H.L.   Sludden J.   Hardy S.C.   Lock R.E.   Hawksworth G.M.   Cassidy J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1623-1627

Elsevier

Access to resources Recommend Favorite